Patents by Inventor Eliot MORRISON

Eliot MORRISON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids for inhibiting expression of PROS1 in a cell
    Patent number: 11820971
    Abstract: The invention relates to nucleic acid products that interfere with or inhibit PROS1 gene expression. It further relates to therapeutic uses of PROS1 inhibition for the treatment of bleeding disorders.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: November 21, 2023
    Assignees: UNIVERSITÄT BERN, SILENCE THERAPEUTICS GMBH
    Inventors: Ute Schaeper, Sibylle Dames, Eliot Morrison, Raja Prince Eladnani, Anne Angelillo-Scherrer
  • NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL
    Publication number: 20230019513
    Abstract: The invention relates to nucleic acid products that interfere with or inhibit PROS1 gene expression. It further relates to therapeutic uses of PROS1 inhibition for the treatment of bleeding disorders.
    Type: Application
    Filed: July 25, 2022
    Publication date: January 19, 2023
    Applicants: UNIVERSITÄT BERN, SILENCE THERAPEUTICS GMBH
    Inventors: Ute SCHAEPER, Sibylle DAMES, Eliot MORRISON, Raja PRINCE ELADNANI, Anne ANGELILLO-SCHERRER
  • NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL
    Publication number: 20220135974
    Abstract: The invention relates to nucleic acid products that interfere with or inhibit PROS1 gene expression. It further relates to therapeutic uses of PROS1 inhibition for the treatment of bleeding disorders.
    Type: Application
    Filed: November 11, 2021
    Publication date: May 5, 2022
    Applicants: UNIVERSITÄT BERN, SILENCE THERAPEUTICS GMBH
    Inventors: Ute SCHAEPER, Sibylle DAMES, Eliot MORRISON, Raja PRINCE ELADNANI, Anne ANGELILLO-SCHERRER